Novartis AG Other Operating Income or Expenses 2010-2024 | NVS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novartis AG annual other operating income or expenses for 2023 were $-0.531B, a 79.32% decline from 2022.
Novartis AG annual other operating income or expenses for 2022 were $-2.568B, a 186.93% increase from 2021.
Novartis AG annual other operating income or expenses for 2021 were $-0.895B, a 38.19% decline from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novartis AG annual other operating income or expenses for 2023 were $-0.531B, a 79.32% decline from 2022.
Novartis AG annual other operating income or expenses for 2022 were $-2.568B, a 186.93% increase from 2021.
Novartis AG annual other operating income or expenses for 2021 were $-0.895B, a 38.19% decline from 2020.